Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GATIFLOXACIN vs GEFITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GATIFLOXACIN vs GEFITINIB: Safety Overview

Metric GATIFLOXACIN GEFITINIB
Total FAERS Reports 341 4,697
Deaths Reported 7 1,047
Death Rate 2.1% 22.3%
Hospitalizations 30 853
Average Patient Age 62.5 yrs 66.4 yrs
% Female Patients 76.2% 66.4%
FDA Approval Date Aug 19, 2011 Apr 26, 2023
Manufacturer Allergan, Inc. Teva Pharmaceuticals, Inc.
Route OPHTHALMIC ORAL
Marketing Status Discontinued Discontinued